DSA will continue to investigate opportunities to widen the analysis of exhaled breath as an indicator for severe diseases. With our state-of-the-art DSA BreathPassTM analyzing device we feel it is possible to come up with solutions for the early indication of developing lung cancer, colon cancers, pneumonia to name a few. We actively look at research and development partners who would like to participate in the future of medical science. Let us know what would be your angle of interest.
